{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:16:08Z","timestamp":1788023768010,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":138,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05771-3","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T05:16:11Z","timestamp":1764393371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study"],"prefix":"10.1186","volume":"30","author":[{"given":"Nico A. F.","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lore","family":"Vanderbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cato","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Feys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan I.","family":"van der Spoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birkitt L.","family":"ten Tusscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole P.","family":"Juffermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen","family":"Aardema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte H. S. B.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Lormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Messiaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kolwijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen A.","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J. A.","family":"Rijnders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Hoiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C. J. J.","family":"Bergmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J. M.","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Wauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"4","key":"5771_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","volume":"196","author":"FL Van de Veerdonk","year":"2017","unstructured":"Van de Veerdonk FL, Kolwijck E, Lestrade PP, Hodiamont CJ, Rijnders BJ, van Paassen J, et al. Influenza-associated aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2017;196(4):524\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"5771_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00134-010-2078-z","volume":"37","author":"I Martin-Loeches","year":"2011","unstructured":"Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med. 2011;37(2):272\u201383.","journal-title":"Intensive Care Med"},{"issue":"3","key":"5771_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1378\/chest.10-1396","volume":"139","author":"I Mart\u00edn-Loeches","year":"2011","unstructured":"Mart\u00edn-Loeches I, Sanchez-Corral A, Diaz E, Granada RM, Zaragoza R, Villavicencio C, et al. Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139(3):555\u201362.","journal-title":"Chest"},{"issue":"9","key":"5771_CR4","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1164\/rccm.201101-0110OC","volume":"183","author":"SH Kim","year":"2011","unstructured":"Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, et al. Corticosteroid treatment in critically ill patients with pandemic influenza A\/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med. 2011;183(9):1207\u201314.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"5771_CR5","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","volume":"38","author":"J Wauters","year":"2012","unstructured":"Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med. 2012;38(11):1761\u20138.","journal-title":"Intensive Care Med"},{"issue":"5","key":"5771_CR6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jinf.2012.07.007","volume":"65","author":"C Guervilly","year":"2012","unstructured":"Guervilly C, Roch A, Ranque S, Forel JM, Hraiech S, Xeridat F, et al. A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia. J Infect. 2012;65(5):470\u20133.","journal-title":"J Infect"},{"issue":"1","key":"5771_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00134-016-4578-y","volume":"43","author":"I Martin-Loeches","year":"2017","unstructured":"Martin-Loeches I, M JS, Vincent JL, Alvarez-Lerma F, Bos LD, Sol\u00e9-Viol\u00e1n J, et al. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med. 2017;43(1):48\u201358.","journal-title":"Intensive Care Med"},{"issue":"9","key":"5771_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jfma.2017.06.002","volume":"116","author":"YH Ku","year":"2017","unstructured":"Ku YH, Chan KS, Yang CC, Tan CK, Chuang YC, Yu WL. Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections. J Formos Med Assoc. 2017;116(9):660\u201370.","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"5771_CR9","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"A Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe A, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782\u201392.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"5771_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/crj.12995","volume":"13","author":"L Huang","year":"2019","unstructured":"Huang L, Zhang N, Huang X, Xiong S, Feng Y, Zhang Y, et al. Invasive pulmonary aspergillosis in patients with influenza infection: a retrospective study and review of the literature. Clin Respir J. 2019;13(4):202\u201311.","journal-title":"Clin Respir J"},{"issue":"5","key":"5771_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1164\/rccm.201910-1931OC","volume":"202","author":"R Nyga","year":"2020","unstructured":"Nyga R, Maizel J, Nseir S, Chouaki T, Milic I, Roger PA, et al. Invasive tracheobronchial aspergillosis in critically ill patients with severe influenza. A clinical trial. Am J Respir Crit Care Med. 2020;202(5):708\u201316.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"5771_CR12","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/cid\/ciaa007","volume":"71","author":"IS Schwartz","year":"2020","unstructured":"Schwartz IS, Friedman DZP, Zapernick L, Dingle TC, Lee N, Sligl W, et al. High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada. Clin Infect Dis. 2020;71(7):1760\u20133.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"5771_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s10096-020-03923-7","volume":"39","author":"F Waldeck","year":"2020","unstructured":"Waldeck F, Boroli F, Suh N, Wendel Garcia PD, Flury D, Notter J, et al. Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study. Eur J Clin Microbiol Infect Dis. 2020;39(10):1915\u201323.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"5771_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jinf.2020.07.036","volume":"81","author":"L Huang","year":"2020","unstructured":"Huang L, Zhai T, Hua L, Zhan Q. Early identification of patients with severe influenza-associated aspergillosis (IAA) in the intensive care unit\u2013an IAA prediction score system (Asper-PreSS). J Infect. 2020;81(4):639\u201346.","journal-title":"J Infect"},{"issue":"6","key":"5771_CR15","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/CCM.0000000000004861","volume":"49","author":"A Coste","year":"2021","unstructured":"Coste A, Fr\u00e9rou A, Raute A, Couturaud F, Morin J, Egreteau PY, et al. The extent of aspergillosis in critically ill patients with severe influenza pneumonia: a multicenter cohort study. Crit Care Med. 2021;49(6):934\u201342.","journal-title":"Crit Care Med"},{"issue":"1","key":"5771_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13054-021-03874-1","volume":"26","author":"A Rouz\u00e9","year":"2022","unstructured":"Rouz\u00e9 A, Lemaitre E, Martin-Loeches I, Povoa P, Diaz E, Nyga R, et al. Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study. Crit Care. 2022;26(1):11.","journal-title":"Crit Care"},{"issue":"2","key":"5771_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jmii.2021.03.005","volume":"55","author":"CW Kuo","year":"2022","unstructured":"Kuo CW, Wang SY, Tsai HP, Su PL, Cia CT, Lai CH, et al. Invasive pulmonary aspergillosis is associated with cytomegalovirus viremia in critically ill patients - a retrospective cohort study. J Microbiol Immunol Infect. 2022;55(2):291\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"5771_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.medin.2021.12.005","volume":"46","author":"L Claverias","year":"2022","unstructured":"Claverias L, Daniel X, Mart\u00edn-Loeches I, Vidal-Cortez P, G\u00f3mez-Bertomeu F, Trefler S, et al. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia. Med Intensiva. 2022;46(8):426\u201335.","journal-title":"Med Intensiva"},{"issue":"1","key":"5771_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13059","volume":"17","author":"F Waldeck","year":"2023","unstructured":"Waldeck F, Boroli F, Zingg S, Walti LN, Wendel-Garcia PD, Conen A, et al. Higher risk for influenza-associated pulmonary aspergillosis (IAPA) in asthmatic patients: a Swiss multicenter cohort study on IAPA in critically ill influenza patients. Influenza Other Respir Viruses. 2023;17(1):e13059.","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"5771_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/23744235.2023.2273381","volume":"56","author":"A Krifors","year":"2024","unstructured":"Krifors A, Blennow O, P\u00e5hlman LI, Gille-Johnson P, Janols H, Lipcsey M, et al. Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study. Infect Dis. 2024;56(2):110\u20135.","journal-title":"Infect Dis"},{"issue":"12","key":"5771_CR21","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5771_CR22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5771_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","volume":"170","author":"W Meersseman","year":"2004","unstructured":"Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med. 2004;170(6):621\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5771_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/cc4823","volume":"10","author":"KH Vandewoude","year":"2006","unstructured":"Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care. 2006;10(1):R31.","journal-title":"Crit Care"},{"issue":"1","key":"5771_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot SI, Taccone FS, den Van Abeele AM, Bulpa P, Meersseman W, Brusselaers N, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"5771_CR26","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","volume":"46","author":"PE Verweij","year":"2020","unstructured":"Verweij PE, Rijnders BJA, Br\u00fcggemann RJM, Azoulay E, Bassetti M, Blot S, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46(8):1524\u201335.","journal-title":"Intensive Care Med"},{"issue":"6","key":"5771_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00134-021-06431-0","volume":"47","author":"L Vanderbeke","year":"2021","unstructured":"Vanderbeke L, Janssen NAF, Bergmans D, Bourgeois M, Buil JB, Debaveye Y, et al. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial. Intensive Care Med. 2021;47(6):674\u201386.","journal-title":"Intensive Care Med"},{"issue":"7","key":"5771_CR28","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/cid\/ciaa010","volume":"71","author":"BJA Rijnders","year":"2020","unstructured":"Rijnders BJA, Schauwvlieghe A, Wauters J. Influenza-associated pulmonary aspergillosis: a local or global lethal combination? Clin Infect Dis. 2020;71(7):1764\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5771_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13613-016-0156-2","volume":"6","author":"D Contou","year":"2016","unstructured":"Contou D, Dorison M, Rosman J, Schlemmer F, Gibelin A, Foulet F, et al. Aspergillus-positive lower respiratory tract samples in patients with the acute respiratory distress syndrome: a 10-year retrospective study. Ann Intensive Care. 2016;6(1):52.","journal-title":"Ann Intensive Care"},{"issue":"4","key":"5771_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","volume":"50","author":"M Bassetti","year":"2024","unstructured":"Bassetti M, Giacobbe DR, Agvald-Ohman C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, et al. Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM. Intensive Care Med. 2024;50(4):502\u201315.","journal-title":"Intensive Care Med"},{"key":"5771_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mib.2021.04.006","volume":"62","author":"IM Dewi","year":"2021","unstructured":"Dewi IM, Janssen NA, Rosati D, Bruno M, Netea MG, Br\u00fcggemann RJ, et al. Invasive pulmonary aspergillosis associated with viral pneumonitis. Curr Opin Microbiol. 2021;62:21\u20137.","journal-title":"Curr Opin Microbiol"},{"issue":"9","key":"5771_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","volume":"12","author":"S Feys","year":"2024","unstructured":"Feys S, Carvalho A, Clancy CJ, Gangneux JP, Hoenigl M, Lagrou K, et al. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients. Lancet Respir Med. 2024;12(9):728\u201342.","journal-title":"Lancet Respir Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05771-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05771-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05771-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T13:38:54Z","timestamp":1777210734000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-025-05771-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5771"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05771-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For participating Dutch centres, the study protocol (CMO 2016\u20133037) was reviewed and approved by the ethics board region Arnhem-Nijmegen before study initiation. Based on the study\u2019s observational nature, written informed consent was waived. Patients were not included if they (or their legal representatives) actively objected to participation.For participating Belgian centres, the study protocol was reviewed and approved by their individual ethical committees (S60757). Written informed consent was obtained for all Belgian participants.Participants in the POSA-FLU trial all provided written informed consent. This study\u2019s protocol was reviewed and approved by the ethics board region Arnhem-Nijmegen for all Dutch participating sites (CMO 2018\u20134041) and by the ethical committees of all participating centres in Belgium (S60744).This study was performed in accordance with the latest version of the declaration of Helsinki and local legislation\/regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NAFJ reports having been a local (principal) investigator for an industry-sponsored trial for Pulmatrix, Inc. (payments to institution), outside the submitted work. LV reports fees from Pfizer and support for attending meetings and\/or travel from Pfizer and Gilead Sciences, outside the submitted work. SF reports fees from HealthBook Company Ltd., Pfizer, Gilead and MundiPharma and support for attending meetings and\/or travel from Pfizer and Gilead, outside the submitted work. KvD reports fees from Gilead and Pfizer (paid to institution) and participating on advisory boards for Gilead and Pfizer (payments to institution), outside the submitted work. KL reports grants from TECOmedical (paid to institution), consulting fees from MundiPharma (paid to institution), fees from Gilead, Pfizer, MundiPharma and FUJIFILM Wako Chemicals Europe GmbH (the latter two paid to institution), support for attending meetings and\/or travel from Gilead, Pfizer and AstraZeneca and participation on a Data Safety Monitoring Board or Advisory Board for Pfizer (paid to institution), all outside the submitted work. RJMB reports grants from Gilead and Pfizer and consulting fees and payment for expert testimony from Basilea, F2G, Gilead, Pfizer, Astellas, MundiPharma and Pulmocide, all outside the submitted work. PEV reports fees from MundiPharma and Gilead Sciences (paid to institution), outside the submitted work. JW reports investigator-initiated grants from Gilead, Pfizer and MundiPharma, speaker\u2019s fees from Gilead, Pfizer, MundiPharma and AstraZeneca and support for attending meetings and\/or travel from Gilead, Pfizer and MundiPharma, all outside the submitted work. FLvdV reports grants from the European Union\u2019s Horizon 2020 research and innovation programme, outside the submitted work. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}